MARA Holdings
MARA
Taylor Morrison Home
TMHC
Lennar Corp
LEN
Toll Brothers
TOL
Apple
AAPL
US Stock MarketDetailed Quotes
EDIT Editas Medicine
- 2.140
- +0.300+16.30%
Trading Feb 27 10:00 ET
176.65MMarket Cap-0.84P/E (TTM)
2.170High1.810Low1.57MVolume1.830Open1.840Pre Close3.20MTurnover1.91%Turnover RatioLossP/E (Static)82.55MShares10.72952wk High1.01P/B175.96MFloat Cap1.12052wk Low--Dividend TTM82.22MShs Float99.950Historical High--Div YieldTTM19.57%Amplitude1.120Historical Low2.036Avg Price1Lot Size
About Editas Medicine Company
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.
Company Profile
SymbolEDIT
Company NameEditas Medicine
Listing DateFeb 3, 2016
Issue Price16.00
Founded2013
CEODr. Gilmore O’Neill, M.B.
MarketNASDAQ
Employees265
Fiscal Year Ends12-31
Address11 Hurley Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02141
Phone1-617-401-9000
Company Executives
- Name
- Position
- Salary
- Dr. Gilmore O’Neill, M.B.
- Director, Chief Executive Officer and President
- 2.39M
- Erick J. Lucera, C.F.A.
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 2.22M
- Linda Burkly
- Executive Vice President and Chief Scientific Officer
- 1.54M
- Andrew J. Hirsch
- Independent Director
- 210.56K
- Bernadette M. Connaughton
- Independent Director
- 215.06K
- Dr. Jessica Hopfield, PhD
- Independent Director
- 231.07K
- Dr. Elliott M. Levy, M.D.
- Independent Director
- 264.88K
- Dr. David T. Scadden, M.D.
- Independent Director
- 213.06K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
